If you have been reading about RP-HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-03-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 0.9 kDa | Depends on exact fragment sequence and counterion |
| Amino acid sequence | LKKTETQ (commonly cited) | Short actin-binding motif from thymosin beta-4 |
| Common salt form | Acetate salt | Trifluoroacetate also reported in research material |
| Reconstitution solvent | Sterile water or buffer | Gentle mixing; avoid vigorous agitation |
| Solution storage | -20 °C or lower | Aliquot to avoid repeated freeze-thaw cycles |
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
== Biological significance == In general, most biochemical reactions are stereoselective, so only one stereoisomer will produce the intended product while the other simply does not participate or can cause side-effects. Of note, the L form of amino acids and the D form of sugars (primarily glucose) are usually the biologically reactive form. This is due to the fact that many biological molecules are chiral and thus the reactions between specific enantiomers produce pure stereoisomers. Also notable is the fact that all amino acid residues exist in the L form. However, bacteria produce D-amino acid residues that polymerize into short polypeptides which can be found in bacterial cell walls. These polypeptides are less digestible by peptidases and are synthesized by bacterial enzymes instead of mRNA translation which would normally produce L-amino acids. The stereoselective nature of most biochemical reactions meant that different enantiomers of a chemical may have different properties and effects on a person. Many psychotropic drugs show differing activity or efficacy between isomers, e.g. amphetamine is often dispensed as racemic salts while the more active dextroamphetamine is reserved for refractory cases or more severe indications; another example is methadone, of which one isomer has activity as an opioid agonist and the other as an NMDA antagonist. Racemization of pharmaceutical drugs can occur in vivo.
In veterinary anesthesia, ketamine is often used for its anesthetic and analgesic effects on cats, dogs, rabbits, rats, and other small animals. It is frequently used in induction and anesthetic maintenance in horses. It is an important part of the "rodent cocktail", a mixture of drugs used for anesthetising rodents. Veterinarians often use ketamine with sedative drugs to produce balanced anesthesia and analgesia, and as a constant-rate infusion to help prevent pain wind-up. Ketamine is also used to manage pain among large animals. It is the primary intravenous anesthetic agent used in equine surgery, often in conjunction with detomidine and thiopental, or sometimes guaifenesin. Ketamine appears not to produce sedation or anesthesia in snails. Instead, it appears to have an excitatory effect.
Ohanin, a minor vespryn protein component specific to this species, causes hypolocomotion and hyperalgesia in experimental mice. It is believed that it contributes to neurotoxicity on the central nervous system of the victim.
=== Electromagnetic cloaking principles for seismic metamaterials === For seismic metamaterials to protect surface structures, the proposal includes a layered structure of metamaterials, separated by elastic plates in a cylindrical configuration. A prior simulation showed that it is possible to create concealment from electromagnetic radiation with concentric, alternating layers of electromagnetic metamaterials. That study is in contrast to concealment by inclusions in a split-ring resonator designed as an anisotropic metamaterial. The configuration can be viewed as alternating layers of homogeneous isotropic dielectric material. Each dielectric material is much thinner than the radiated wavelength. As a whole, such a structure is an anisotropic medium. The layered dielectric materials surround a conducting cylinder. The layered dielectric materials radiate outward, in a concentric fashion, and the cylinder is encased in the first layer. The other layers alternate and surround the previous layer all the way to the first layer. Electromagnetic wave scattering was calculated and simulated for the layered (metamaterial) structure and the split-ring resonator anisotropic metamaterial, to show the effectiveness of the layered metamaterial.
David Crocker, a member of the ARPANET research community, writing in the Post, said, "The reports incorrectly credited [EMAIL's] author, a 14-year-old in the late 1970s, as the 'inventor' of email, long after it had become an established service on the ARPANET." Another computer historian, Marc Weber, a curator at the Computer History Museum, said that by 1978, "nearly all the features we're familiar with today had appeared on one system or another over the previous dozen years", including emoticons, mailing lists, and spam mail. After the controversy unfolded, MIT disassociated itself from Ayyadurai's EMAIL Lab and funding was dropped. MIT also revoked Ayyadurai's contract to lecture at the bioengineering department. Ayyadurai characterized the earlier work of Tomlinson, Tom Van Vleck and others as text messaging, rather than an electronic version of an interoffice mail system.
Sources: en.wikipedia.org
Vericrustacea ("true crustaceans")—Branchiopoda, Copepoda, Malacostraca, Thecostraca. Multicrustacea ("numerous crustaceans")—Copepoda, Malacostraca, Thecostraca. Communostraca ("common shelled ones")—Malacostraca, Thecostraca. Miracrustacea ("surprising crustaceans")—Cephalocarida, Remipedia, Hexapoda. Xenocarida ("strange shrimp")—Cephalocarida, Remipedia. Of these proposed clades, only Multicrustacea was confirmed in later molecular studies.
The film Deadpool & Wolverine (2024) features many returning characters and actors, including Ryan Reynolds as Wade Wilson / Deadpool, Hugh Jackman as a version of Logan / Wolverine, and Chris Evans—who starred as Steve Rogers / Captain America in the Infinity Saga—as Johnny Storm / Human Torch, reprising his role from Fox's Fantastic Four duology (2005–2007). Feige said Deadpool & Wolverine was the true start to Marvel Studios' use of the Fox characters, and began the MCU's "Mutant era". He said Fox characters would continue to appear through Doomsday and Secret Wars, which would introduce a "new age of mutants and of the X-Men" as part of a reported ten-year plan for the characters. Feige added that one of Marvel's goals for the crossover films was to give closure to storylines that pre-dated the MCU, including those of the Fox X-Men characters, before Secret Wars introduced a recast X-Men team. Doomsday sees additional X-Men film series actors reprising their roles: Ian McKellen (Erik Lehnsherr / Magneto), Alan Cumming (Kurt Wagner / Nightcrawler), Rebecca Romijn (Raven Darkhölme / Mystique), and James Marsden (Scott Summers / Cyclops). The Phase Six film The Fantastic Four: First Steps (2025) introduces Pedro Pascal, Vanessa Kirby, Ebon Moss-Bachrach, and Joseph Quinn as a new version of the Fantastic Four for the MCU. Sadie Sink is introduced as a new version of Jean Grey in Spider-Man: Brand New Day (2026), with that film also featuring Bill Metzger, a radical anti-mutant activist in the comics; and a universal inhibitor that subdues mutant abilities.
Tight junctions are very important in embryo development. In the blastula, these cadherin mediated cell interactions are essential to development of epithelium which are most important to paracellular transport, maintenance of cell polarity and the creation of a permeability seal to regulate blastocoel formation. These tight junctions arise after the polarity of epithelial cells is established which sets the foundation for further development and specification. Within the blastula, inner blastomeres are generally non-polar while epithelial cells demonstrate polarity. Mammalian embryos undergo compaction around the 8-cell stage where E-cadherins as well as alpha and beta catenins are expressed. This process makes a ball of embryonic cells which are capable of interacting, rather than a group of diffuse and undifferentiated cells. E-cadherin adhesion defines the apico-basal axis in the developing embryo and turns the embryo from an indistinct ball of cells to a more polarized phenotype which sets the stage for further development into a fully formed blastocyst. Xenopus membrane polarity is established with the first cell cleavage. Amphibian EP-cadherin and XB/U cadherin perform a similar role as E-cadherin in mammals establishing blastomere polarity and solidifying cell-cell interactions which are crucial for further development.
CCPs can be a valuable resource of genetic material. They can be used to preserve valuable genetic diversity for future use, or as base for new breeding programs. Promising plants can be selected and multiplied, generating new varieties. It is legal under EU law to sell and buy seeds from a composite cross population as an experiment in the period between 2014 and 2018. In 2000, with the help of plant breeders and the Organic Research Centre, the scientist Martin Wolfe crossed 20 varieties of wheat (selected for quality and yield) and crossed them to obtain 190 new crosses. These seeds were not further selected and planted, grown, harvested and reseeded together as a population. Martin Wolfe called it YQ, for "yield" and "quality". Wolfe lobbied in Brussels and Westminster to receive an exception to the EU regulations that would allow YQ to be sold. In 2014, it was accepted and since 2017 the YQ seed, officially called the "ORC Wakelyns Population" was the first population wheat to go on sale in Europe.
Sources: en.wikipedia.org
Most commonly drowsiness, blurred vision, headache, nausea, and skin rash. Possible clumsiness (ataxia), upset stomach, flushing, mood changes, trouble urinating, itchiness, and fever. Both tachycardia (fast heart rate) and bradycardia (slow heart rate) have been reported. Hypersensitivity reactions and anaphylatic reactions are also reported. May cause respiratory depression when combined with benzodiazepines, barbiturates, codeine, or other muscle relaxants. May cause urine to turn black, blue, or green. While the product label states that methocarbamol can cause jaundice, there is minimal evidence to suggest that methocarbamol causes liver damage. During clinical trials of methocarbamol, there were no laboratory measurements of liver damage indicators, such as serum transaminase (AST/ALT) levels, to confirm hepatotoxicity. Although unlikely, it is impossible to rule out that methocarbamol may cause mild liver injury with use.
After escaping in the present, he seeks out his ex-girlfriend Myra and pilots a ninja-themed Kaijuki called Shinobi Shadow (シノビシャドー, Shinobi Shadō) to stop the Dekarangers, who destroy the Kaijuki with Dekaranger Robo before deleting Sheik with the D-Bazooka. Sheik is voiced by Hideaki Kusaka (日下 秀昭, Kusaka Hideaki). Bileezian Vino (ビリーザ星人ヴィーノ, Birīza Seijin Vīno): An old academy friend of Hoji's from Planet Bileez who retired from S.P.D. out of disenchantment, was lured into a criminal lifestyle by the money he earned from his skills, became a mercenary, reconfigured his body into a monstrous form, and assumed the identity of Gigandes (ギガンテス, Gigantesu) to commit indiscriminate mass murder. In the present, he is hired by Ben G and Agent Abrella to assassinate Kruger and retrieve information on the Deka Base, respectively. Vino succeeds in the latter task before he enlarges himself and is deleted by Dekaranger Robo. Vino is voiced by Naoya Gomoto (郷本 直也, Gōmoto Naoya), who also portrays his original form. Kajimerian Ben G (カジメリ星人ベン・G, Kajimeri Seijin Ben G): A criminal from Planet Kajimeri who was charged with mass-murder and swore revenge on Kruger, following a near-death experience amidst a chase between them that turned the former into a cyborg. As part of his revenge, Ben G tasks a Batsuroid with piloting a drill-themed Kaijuki called Terrible Terror (テリブルテーラー, Teriburu Tērā) to distract the Dekarangers while he infiltrates the Deka Base and kidnaps Swan Shiratori. Terrible Terror is destroyed by Dekaranger Robo, while Ben G is deleted by Deka Master.
TikTok has since apologized and instituted a ban against anti-LGBTQ ideology, but censorship continues on Douyin due to regulations in China. Douyin guidelines also forbid live broadcasting by unregistered foreigners, "feudal superstition", "money worship", smoking and drinking, competitive eating by the "already obese", "toxic" slime, "pornographic" ASMR such as ear-licking, and female anchors wearing revealing clothes. ByteDance said its early guidelines were global and aimed at reducing online harassment and divisiveness when its platforms were still growing. They have been replaced by versions customized by local teams for users in different regions. A March 2021 study by the Citizen Lab found that TikTok did not censor searches politically but was inconclusive about whether posts are. A 2023 paper by the Internet Governance Project at Georgia Institute of Technology concluded that TikTok is "not exporting censorship, either directly by blocking material, or indirectly via its recommendation algorithm." After increased scrutiny, TikTok said it is granting some outside experts access to the platform's anonymized data sets and protocols, including filters, keywords, criteria for heating, and source code.
In many animals it is converted to pyruvate via threonine dehydrogenase. An intermediate in this pathway can undergo thiolysis with CoA to produce acetyl-CoA and glycine. In humans the gene for threonine dehydrogenase is an inactive pseudogene, so threonine is converted to α-ketobutyrate. The mechanism of the first step is analogous to that catalyzed by serine dehydratase, and the serine and threonine dehydratase reactions are probably catalyzed by the same enzyme. In many organisms it is O-phosphorylated by a kinase preparatory to further metabolism. This is especially important in bacteria as part of the biosynthesis of cobalamin (Vitamin B12), as the product is converted to (R)-1-aminopropan-2-ol for incorporation into the vitamin's sidechain. Threonine is used to synthesize glycine during the endogenous production of L-carnitine in the brain and liver of rats.
== Human genes == 45S: RNR1, RNR2, RNR3, RNR4, RNR5; (unclustered) RNA18SN1, RNA18SN2, RNA18SN3, RNA18SN4, RNA18SN5, RNA28SN1, RNA28SN2, RNA28SN3, RNA28SN4, RNA28SN5, RNA45SN1, RNA45SN2, RNA45SN3, RNA45SN4, RNA45SN5, RNA5-8SN1, RNA5-8SN2, RNA5-8SN3, RNA5-8SN4, RNA5-8SN5 5S: RNA5S1, RNA5S2, RNA5S3, RNA5S4, RNA5S5, RNA5S6, RNA5S7, RNA5S8, RNA5S9, RNA5S10, RNA5S11, RNA5S12, RNA5S13, RNA5S14, RNA5S15, RNA5S16, RNA5S17 Mt: MT-RNR1, MT-TV (co-opted), MT-RNR2
Sources: en.wikipedia.org
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.
Reversed-phase liquid chromatography separates components and reports purity from peak area. Mass spectrometry confirms the molecular mass expected for the sequence. Additional approaches such as peptide mapping or amino acid analysis provide independent confirmation.
Reported percentages depend on the analytical method, the detection wavelength, and whether salts and water are counted. A value above ninety-five percent by chromatography does not by itself establish a correct sequence. Different suppliers also calculate purity against different reference standards.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.